Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib Front-Line, in Real-Life Conditions: Influence of Switching to Another TKI Prior to Cessation.
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:3918-3919 - Subject
- Language
- ISSN
- 0006-4971